 Comparison cyclosporine D-penicillamine rheumatoid arthritis randomized double blind multicenter study Ninety-two patients active rheumatoid arthritis RA randomized double blind study weeks cyclosporine initial mg/kg D-penicillamine initial mg groups baseline characteristics cyclosporine group patients inefficacy D-penicillamine group patients inefficacy antirheumatic drugs effective disease activity significant decrease erythrocyte sedimentation rate D-penicillamine treatment conditions trial cyclosporine alternative D-penicillamine treatment patients RA